Drugs / ABT-652
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01124851 | Aug 2010 → Apr 2011 | sleep disorder | Abbott | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT01579279 | Apr → May 2012 | diabetic neuropathy | AbbVie | Terminated | No outcome recorded |
| Phase 2 | NCT01444365 | Oct 2011 → Apr 2012 | osteoarthritis, knee | AbbVie | Completed | No outcome recorded |
| Phase 2 | NCT01207115 | Sep 2010 → May 2011 | osteoarthritis, knee | AbbVie | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABT-652 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01207115 ↗ |
| Route | Oral | “ABT-652 Dose 1 vs placebo capsules administered orally once daily for 7 days” NCT01124851 ↗ |